MREO vs AAPL: Which Stock is Better?
Side-by-side comparison of Mereo Biopharma Group Plc and Apple Inc in 2026
MREO
Mereo Biopharma Group Plc
$0.57
AAPL
Apple Inc
$245.82
Key Metrics Comparison
| Metric | MREO | AAPL | Winner |
|---|---|---|---|
| Market Cap | $89.93M | $3.66T | AAPL |
| P/E Ratio | N/A | 33.85 | AAPL |
| EPS (TTM) | $N/A | $7.55 | AAPL |
| Revenue Growth | 0.0% | 6.4% | AAPL |
| Gross Margin | 73.4% | 46.9% | MREO |
Analyze MREO
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is MREO or AAPL a better investment?
Comparing MREO and AAPL: Mereo Biopharma Group Plc has a market cap of $89.93M while Apple Inc has $3.66T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between MREO and AAPL?
MREO (Mereo Biopharma Group Plc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: MREO or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: MREO or AAPL?
AAPL has higher revenue growth at 6.4% vs 0.0% for MREO.
Which company is more profitable: MREO or AAPL?
Mereo Biopharma Group Plc (MREO) has higher gross margins at 73.4% compared to 46.9% for AAPL.
Which is the larger company: MREO or AAPL?
Apple Inc (AAPL) is larger with a market cap of $3.66T compared to $89.93M for MREO.
Should I buy MREO or AAPL in 2026?
Both MREO and AAPL have investment merit. MREO trades at $0.57 while AAPL trades at $245.82. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between MREO and AAPL stock?
Key differences: Market Cap ($89.93M vs $3.66T), P/E Ratio (N/A vs 33.8x), Revenue Growth (0.0% vs 6.4%), Gross Margin (73.4% vs 46.9%).